Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors.
Kurzrock, R., Gabrail, N., Chandhasin, C., Moulder, S., Smith, C., Brenner, A., Sankhala, K., Mita, A., Elian, K., Bouchard, D. & Sarantopoulos, J.
Molecular Cancer Therapeutics 11(2):308-16. doi: 10.1158/1535-7163.MCT-11-0566 (2012). PMID:22203732
http://www.ncbi.nlm.nih.gov/pubmed/?term=22203732